Search clinical trials for: Hypolipidemic Agents

Total 189034 results

October 6 University
Beni-Suef University

Not yet recruiting

Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD) (MAFLD)

Fatty Liver | Fatty Liver Disease

Egypt
Singapore General Hospital
National Medical Research Council (NMRC), Singapore

Unknown

Effects of Fenofibrate Therapy in Diabetic Nephropathy

Diabetes Mellitus | Diabetic Nephropathies

Singapore
University of Aarhus

Completed

Effect of Pharmacological Anti-lipolysis on FFA and VLDL-TG Metabolism Before and During Exercise

Obesity | Diabetes

Denmark
First People's Hospital of Hangzhou

Recruiting

Safety Study of Fenofibrate During Pregnancy

Severe Hypertriglyceridemia During Pregnancy

China
Solvay Pharmaceuticals

Completed

Effects of Fenofibrate on Gene Expression in Healthy Volunteers

Healthy

United Kingdom
University of California, San Diego

Completed

Effect of Ezetimibe on Flow-mediated Brachial Artery Reactivity in Healthy Subjects

Endothelial Dysfunction
University Medical Centre Ljubljana

Completed

The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients

Dyslipidemia | Transplants

Slovenia
Yokohama City University Medical Center

Unknown

The Effects of Ezetimibe on Coronary Plaque Volume in Patients With Acute Coronary Syndrome

Coronary Artery Disease

Japan
Canadian Medical and Surgical Knowledge Translation...
Amgen

Recruiting

A Study of Evolocumab on Carotid Artery Atherosclerotic Plaque Morphology Prior to Carotid EndArterectomy (SLICE-CEA)

Carotid Artery Stenosis | Asymptomatic Carotid Artery Stenosis

Canada
Federico II University

Recruiting

Subclinical Atherosclerosis in Patients With Familial Hypercholesterolemia Treated With Evolocumab®

Hypercholesterolemia, Familial

Italy
Organon and Co

Completed

Effect of Ezetimibe Treatment on Low-density Lipoprotein Cholesterol (LDL-C) Levels in Participants With Coronary Heart Disease (CHD) Already Treated With a Statin (MK-0653A-205 AM1) (ACT II)

Hypercholesterolemia
Hamid Al-Essa Organ Transplant Center

Completed

PCSK 9 Inhibition as Secondary Prevention in Renal Transplant Patients

Kideny Transplant Recipients With High Cardiovascular Risk Score

Kuwait
Beijing Anzhen Hospital

Unknown

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With High Risk Coronary Artery Disease (FORWARD) (FORWARD)

Dyslipidemia | High Risk Coronary Artery Disease

China
Ziauddin Hospital

Unknown

Ezetimibe for Patients With Chronic Hepatitis D

Chronic Hepatitis D

Pakistan
University of Arkansas
National Institutes of Health (NIH)

Withdrawn

Tissue Lipids and Insulin Resistance

Tissue Lipid Metabolism
National Institute of Allergy and Infectious Diseases...

Completed

Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults

HIV Infections

United States, Puerto Rico
Canadian Collaborative Research Network
Schering-Plough

Completed

Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With Atherosclerosis

Coronary Artery Disease | Obesity | Metabolic Syndrome

Canada
Alessandro Doria
University of Michigan; University of Minnesota

Recruiting

A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes (PERL-FENO)

Diabetic Nephropathies

United States
Indonesia University

Completed

Effects of Oral Fenofibrate on Retinal Thickness and Macular Volume

Diabetes Mellitus | Diabetic Retinopathy | Dyslipidemias
Newcastle-upon-Tyne Hospitals NHS Trust
Newcastle University

Completed

A Study of Bezafibrate in Mitochondrial Myopathy

Mitochondrial Diseases

United Kingdom
Instituto Mexicano del Seguro Social

Completed

Bezafibrate for Hyperfibrinogenemia in Acute Myocardial Infarction (BEZAFIBRAMI)

Acute Myocardial Infarction
Zydus Lifesciences Limited

Completed

A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia

Dyslipidemia | Hypertriglyceridemia

India
Jaeb Center for Health Research
Juvenile Diabetes Research Foundation; Roche Pharma AG; National Eye Institute... and other collaborators

Recruiting

Fenofibrate for Prevention of DR Worsening (Protocol AF)

Diabetic Retinopathy

United States
Massachusetts General Hospital
Brain & Behavior Research Foundation; J Willard and Alice S. Marriott Foundation

Recruiting

BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study

Bipolar Disorder | Depressive Episode

United States
Mansoura University

Completed

Fenofibrate Therapy in Pathological Unconjugated Hyperbilirubinemia in Full Term Infants

Neonatal Jaundice
Second Affiliated Hospital of Soochow University

Unknown

Evaluation of Fenofibrate on Radiation-induced Skin Injury

Radiodermatitis

China
University of Miami
University of Florida

Terminated

Pilot Study of Fenofibrate for PSC

Primary Sclerosing Cholangitis

United States
Lawson Health Research Institute

Terminated

Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Canada
University of California, Irvine

Completed

Safety and Efficacy of Fenofibrate as a Treatment for Huntington's Disease

Huntington Disease

United States
Solvay Pharmaceuticals

Terminated

Effect of Fenofibrate on Sleep Apnea Syndrome

Obesity | Overweight | Dyslipidemia | Sleep Apnea Syndrome

France
University of Aarhus

Terminated

Metabolic Modulation as Treatment in Acute Heart Failure (MEMO)

Acute Heart Failure

Denmark
Second Affiliated Hospital of Guangxi Medical University

Not yet recruiting

Safety and Efficacy of Evolocumab in Ischemic Stroke (SEEIS)

Ischemic Stroke, Acute
Xijing Hospital of Digestive Diseases

Recruiting

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

China
Assistance Publique - Hôpitaux de Paris

Completed

Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis (BEZURSO)

PBC

France
Robert Rosenson
University of Michigan; University of Toronto; Amgen

Completed

The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease

Type2 Diabetes | Microvascular Dysfunction | Atherosclerotic Vascular Disease

United States, Canada
Johns Hopkins University
American Heart Association

Completed

Effect of Evolocumab on Coronary Endothelial Function (EVOLVE)

Coronary Artery Disease | Human Immunodeficiency Virus

United States
Eli Lilly and Company

Completed

A Study of Evacetrapib (LY2484595) in Participants With Severe Renal Impairment and in Healthy Participants

Cardiovascular Disease

United States
Eli Lilly and Company

Completed

A Study of Evacetrapib in Participants With Abnormal Cholesterol

Dyslipidemia

United States
Pontificia Universidad Catolica de Chile

Unknown

Pilot Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection (EZE-1)

Chronic Hepatitis C

Chile
University of Palermo

Unknown

Lifestyle Versus Ezetimibe Plus Lifestyle in Patients With Non-alcoholic Steatohepatitis

•Non-alcoholic Steatohepatitis (NASH)

Italy
Hotel Dieu de France Hospital
Pharmaline, Lebanon

Completed

Effect of Ezetimibe on Oxidized Low-density Lipoprotein (LDL) Cholesterol

Coronary Artery Disease | Diabetes

Lebanon
Gachon University Gil Medical Center

Completed

Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic Patients

Hypertriglyceridemia

Korea, Republic of
Tianjin Chest Hospital

Recruiting

Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in Patients With Acute Coronary Syndrome (EMSIACS)

Acute Coronary Syndrome | Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor

China
Xijing Hospital of Digestive Diseases

Recruiting

Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid

Primary Biliary Cirrhosis

China
University of California, Los Angeles
Amgen

Terminated

Reducing Intracranial atheroSclErosis With Repatha (RISER)

Ischemic Stroke

United States
DalCor Pharmaceuticals
Covance; The Montreal Health Innovations Coordinating Center (MHICC)

Completed

Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19

Covid19

Canada
Hoffmann-La Roche

Terminated

A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease

Cardiovascular Disease

Poland, United States, Switzerland, Canada, Germany
Pontificia Universidad Catolica de Chile

Unknown

Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection in Liver Transplant Candidates (EZE-2) (EZE-2)

Hepatitis C

Chile
Merck Sharp & Dohme LLC

Completed

Pharmacokinetics of Anacetrapib (MK0859) in Patients With Hepatic Insufficiency (MK-0859-039)

Dyslipidemia
Merck Sharp & Dohme LLC

Completed

Pharmacokinetics of Anacetrapib (MK0859) in Subjects With Impaired Renal Function (MK-0859-038)

Dyslipidemia

Search clinical trials for: Hypolipidemic Agents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations